In fact, earlier studies could demonstrate that the LCK gene encodes antigenic epitopes recognized by HLA class I-restricted and tumor-specific cytotoxic T lymphocytes (CTLs) of metastatic cancer patients. Here, LCK is linked to metastatic malignant neoplasm.